Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK
Abstract Muscle-specific kinase (MuSK) is crucial for acetylcholine receptor (AChR) clustering and thereby neuromuscular junction (NMJ) function. NMJ dysfunction is a hallmark of several neuromuscular diseases, including MuSK myasthenia gravis. Aiming to restore NMJ function, we generated several ag...
Main Authors: | Jamie L. Lim, Roy Augustinus, Jaap J. Plomp, Kasra Roya-Kouchaki, Dana L. E. Vergoossen, Yvonne Fillié-Grijpma, Josephine Struijk, Rachel Thomas, Daniela Salvatori, Christophe Steyaert, Christophe Blanchetot, Roeland Vanhauwaert, Karen Silence, Silvère M. van der Maarel, Jan J. Verschuuren, Maartje G. Huijbers |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-32641-1 |
Similar Items
-
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
by: Koneczny, I, et al.
Published: (2014) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
by: Koneczny, I, et al.
Published: (2014) -
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
by: Leite, M, et al.
Published: (2005) -
Myasthenia gravis with MuSK antibodies
by: Farrugia, M, et al.
Published: (2005) -
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
by: Phillips, W, et al.
Published: (2015)